Spencer Pharmaceutical Inc.
SPPH
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 06/30/2010 | 03/31/2010 | |||
|---|---|---|---|---|---|
| Net Income | -754.50K | -56.40K | -56.40K | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 9.40K | 1.50K | 1.50K | ||
| Change in Net Operating Assets | 1.28M | 108.60K | 108.60K | ||
| Cash from Operations | 536.70K | 53.70K | 53.70K | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -147.40K | -81.80K | -81.80K | ||
| Cash from Investing | -147.40K | -81.80K | -81.80K | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 12.80K | 27.80K | 27.80K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 55.50K | -- | -- | ||
| Cash from Financing | 68.30K | 27.80K | 27.80K | ||
| Foreign Exchange rate Adjustments | -1.90K | 300.00 | 300.00 | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 455.60K | -- | -- | ||